First Clinical Trial on AVA’s bracelet for real-time pre-symptomatic detection of COVID
More than 20,000 Participants Will Test AVA-Developed Algorithm in Early Detection!
Ava received FDA clearance for its Fertility Tracker
AVA is pleased to announce they received FDA clearance for their Ava Fertility Tracker.
Ava participates in a study on early detection of Covid-19 infection
Our portfolio company, AVA participates in the COVI-GAPP study recently launched by Liechtenstein scientists and entrepreneurs Professor Dr. Lorenz Risch and Dr. Martin Risch.
Coronavirus is good for the fertility business – so says AVA CEO
Coronavirus is good for the fertility business – so says Lea von Bidder, co-founder and CEO of our portfolio company AVA, which markets femtech device to help women track their fertility.
Ava announces Hong Kong launch and one-year “Pregnancy Guarantee”
Our portfolio company AVA further expands in Asia and introduces one-Year “Pregnancy Guarantee”
More than 1’000 babies born to users of AVA’s fertility tracking
More than 1’000 babies born to users of AVA’s fertility tracking
